1 Onkologisk Klinik, Finsencentret, Rigshospitalet, The Capital Region of Denmark2 Finsenlaboratoriet, Finsencentret, Rigshospitalet, The Capital Region of Denmark3 Patologiafdelingen, Diagnostisk Center, Rigshospitalet, The Capital Region of Denmark4 Neurokirurgisk Klinik, Neurocentret, Rigshospitalet, The Capital Region of Denmark5 Gastrounit, Surgical Division, Gastrounit, Amager and Hvidovre Hospital, The Capital Region of Denmark
an observational study of a cohort of consecutive non-selected patients from a single institution
Although implementation of temozolomide (TMZ) as a part of primary therapy for glioblastoma multiforme (GBM) has resulted in improved patient survival, the disease is still incurable. Previous studies have correlated various parameters to survival, although no single parameter has yet been identified. More studies and new approaches to identify the best and worst performing patients are therefore in great demand.